ArticleBlood advances2023

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.

Stéphane de Botton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.